Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
09/2002
09/12/2002US20020127608 Method for selecting compounds from a combinatorial or other chemistry library for efficient synthesis
09/12/2002US20020127606 Detecting bactericides; obtain polypeptide sample, incubate with modulators, monitor activity of polypeptide, reduction in activity indicate bactericide
09/12/2002US20020127603 Methods for synthesizing reporter labeled beads
09/12/2002US20020127601 Detecting modulators of g-protein coupled receptor activity; obtain cell containing g-protein coupled receptor pathway, incubate with modulator, determine quantative and qualitative effect of modulator on receptor
09/12/2002US20020127596 murF2
09/12/2002US20020127593 Fluorescence assay for DNA modifying enzymes
09/12/2002US20020127592 Method for amplifying RNA
09/12/2002US20020127591 Methods and systems for monitoring intracellular binding reactions
09/12/2002US20020127590 Nucleic acid binding enhancement by conjugation with nucleotides, nucleosides, bases and/or their analogues
09/12/2002US20020127588 Apparatus which prevents evaporation and for use in the hybridization of probes and biopolymers
09/12/2002US20020127585 Apparatus for use in the detection and diagnosis of cancer
09/12/2002US20020127584 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/12/2002US20020127581 Screening signaling aptamers in vitro; obtain pool of nucleotide sequences, amplify, transcribe, apply to column, generate complimentary nucleotide sequences, recover signaling aptamers
09/12/2002US20020127580 Methods and devices for collecting, handling and processing mammary fluid samples for evaluating breast diseases, including cancer
09/12/2002US20020127579 Breast carcinoma-associated gene
09/12/2002US20020127578 Compositions and methods relating to prostate specific genes and proteins
09/12/2002US20020127576 Nucleotide sequences coding polypeptide for use in diagnosis and treatment of cancer, nervous system and blood disorders
09/12/2002US20020127575 Generating double stranded nucleotide sequences with single stranded tail; obtain nucleotide sequences, incubate with primer, expose to nuclease, denature nucleotide sequences, recover products
09/12/2002US20020127574 Detecting genetically engineered nucleotide sequences; obtain nucleotide sequences, join to nanoparticles, incubate with probe, monitor adjustment in nucleotide sequence activity
09/12/2002US20020127573 Diagnosing preferential dermatitis in humans; obtain cells, recover nucleotide sequences, screen for gene coding cytokines, monitor expression of cytokine, amplfied cytokine concentration indicates dermatitis
09/12/2002US20020127572 Method of predicting the clinical response to chemotherapeutic treatment with alkylating agents
09/12/2002US20020127571 Method for simultaneous identification of differentially expressed mRNAs and measurement of relative concentrations
09/12/2002US20020127570 Methods for using mutant RNA polymerases with reduced discrimination between non-canonical and canonical nucleoside triphosphates
09/12/2002US20020127569 Two-step hybridization and capture of a polynucleotide
09/12/2002US20020127566 DNA analysis system
09/12/2002US20020127564 Monitoring modulators of phenotypic expression in mammalian cells; obtain cell, transform, screen transformed cells for preferential phenotype
09/12/2002US20020127561 Detecting preferential nucleotide sequeces in sample; obtain a sample of nucleotide sequences, incubate with probes, expose to light, monitor scattered light
09/12/2002US20020127560 High throughput screening for novel enzymes
09/12/2002US20020127559 Pharmacogenomics and identification of drug targets by reconstruction of signal transduction pathways based on sequences of accessible regions
09/12/2002US20020127558 Genetic polymorphism of MxA protein and use thereof
09/12/2002US20020127555 Diagnosing endometriosis in humans; obtaining a sample of endometrial cells, screen sample for expression of endometrial gene marker, expression of marker gene indicates endometriosis
09/12/2002US20020127554 Pyrophosphorolysis activated polymerization (PAP): application to allele-specific amplification and nucleic acid sequence determination
09/12/2002US20020127553 Apoptin-associating protein
09/12/2002US20020127552 Replica amplification of nucleic acid arrays
09/12/2002US20020127551 Oligonucleotide labels for use as detection tools in sequence analysis
09/12/2002US20020127550 Nucleic acid sequences and methods for identifying compounds that affect rna/rna binding protein interactions and mrna functionality
09/12/2002US20020127549 Combining sample with first nucleic acid or nucleic acid molecule comprising an electrochemiluminescent label and hybridized to a complementary second nucleic acid or nucleic acid molecule; incubating; capturing; measuring
09/12/2002US20020127548 Methods for detecting mutations associated with hypertrophic cardiomyopathy
09/12/2002US20020127547 Detection and identification of bacterial strains
09/12/2002US20020127546 Detection and characterization of microorganisms
09/12/2002US20020127545 Assessment of human papilloma virus-related disease
09/12/2002US20020127540 Detecting modulators of bone morphogenic activities; obtain cells, incubate with modulator, monitor expression of reporter molecules, compare to control
09/12/2002US20020127539 Detecting polymorphic receptor with adjusted signaling; obtain cells, transfect with vector containing receptor polypeptide, measure adjustment in reporter molecule expression
09/12/2002US20020127538 Modifications of the VEGF receptor-2 protein and methods of use
09/12/2002US20020127239 LipL32 polypeptide is useful for inducing an immune response to a pathogenic spirochete in a patient
09/12/2002US20020127235 Identification and molecular characterization of proteins, expressed in the Ixodes ricinus salivary glands
09/12/2002US20020127226 Tyrosine phosphatase receptor protein- tenascin ligand complex
09/12/2002US20020127217 A polynucleotides which identify and encode Phosphatidylinositol 4,5-bisphosphate 5-phosphatase (polypeptide)
09/12/2002US20020127214 RAC-protein kinase as therapeutic agent or in diagnostics
09/12/2002US20020125214 Silver stain removal by chemical etching and sonication
09/12/2002US20020125194 Immobilizing receptors on artificial membrane supports, exposing the supports with recepotrs to the test agents at varying concentration in liquid chromatographic system, eluting the test agent, evaluating profile of test material
09/12/2002US20020125192 Nanostructured devices for separation and analysis
09/12/2002US20020125136 Spectral calibration of fluorescent polynucleotide separation apparatus
09/12/2002DE10207028A1 Spritzgießmaschine Injection molding machine
09/12/2002DE10155999A1 Determining the condition of exo- and endo-skeleton in animals, for selecting animals for breeding, comprises a method based on genotype of the diastrophic dysplasia sulfate transporter gene
09/12/2002DE10111392A1 Bioanalytisches Messverfahren unter Verwendung von Oxidasen Bioanalytical measurement methods using oxidases
09/12/2002DE10109855A1 Polypeptide eines p53-Protein-spezifischen murinen alpha/beta T-Zell Rezeptors, diese kodierende Nukleinsäuren und deren Verwendung Polypeptide of a p53 protein specific murine alpha / beta T-cell receptor nucleic acids encoding these, and their use
09/12/2002DE10109854A1 Polypeptide eines hdm2-Protein spezifischen murinen alpha/beta T-Zell Rezeptors, diese kodierende Nukleinsäuren und deren Verwendung Polypeptides of hdm2 protein specific murine alpha / beta T-cell receptor nucleic acids encoding these, and their use
09/12/2002DE10109813A1 Tumor-Peptidantigen aus humanem mdm2 Proto-Onkogen Tumor antigen peptide from human MDM2 proto-oncogene
09/12/2002DE10109012A1 Early diagnosis and monitoring of caries, by molecular-genetic detection of bacterial markers, especially Streptococcus of the mutans group
09/12/2002DE10108900A1 Ermittlung des patientenbezogenen Kariesrisikos Determination of patient-related risk of caries
09/12/2002DE10108453A1 Massenspektrometrische Mutationsanalyse mit photolytisch spaltbaren Primern Mass spectrometric mutation analysis with photolytically cleavable primers
09/12/2002DE10107317A1 Methode zur Detektion von Mutationen Method for the detection of mutations
09/12/2002CA2853831A1 Method for rapid detection and identification of bioagents
09/12/2002CA2743731A1 Method of modulating the proliferation of medullary thyroid carcinoma cells
09/12/2002CA2476611A1 Use of metabolic phenotyping in individualized treatment with amonafide
09/12/2002CA2445018A1 Tumour peptide antigen produced from human mdm2 proto-oncogene
09/12/2002CA2445013A1 Polypeptides of an hdm2 protein-specific murine alpha/beta t-cell receptor, nucleic acids encoding these and their use
09/12/2002CA2445004A1 Polypeptides of a p53 protein-specific murine alpha/beta t-cell receptor, nucleic acids encoding these and their use
09/12/2002CA2440138A1 Automated immunohistochemical and in situ hybridzation assay formulations
09/12/2002CA2439990A1 Immunogenic hiv peptides for use as reagents and vaccines
09/12/2002CA2439986A1 Cell visual characteristic-modifying sequences
09/12/2002CA2439941A1 Secreted proteins
09/12/2002CA2439899A1 Improved skin substitutes and uses thereof
09/12/2002CA2439854A1 Method for the development of gene panels for diagnostic and therapeutic purposes based on the expression and methylatoin status of the genes
09/12/2002CA2439843A1 Compositions and methods for increasing amino acid absorption in mammals
09/12/2002CA2439795A1 Method for the amplification and detection of dna using a transcription based amplification
09/12/2002CA2439779A1 Methods, systems and computer program products for determining the biological effect and/or activity of drugs, chemical substances and/or pharmaceutical compositions based on their effect on the methylation status of the dna
09/12/2002CA2439655A1 Method for rapid detection and identification of bioagents
09/12/2002CA2439636A1 Mouse cytokine receptor
09/12/2002CA2439620A1 Viral reporter particles
09/12/2002CA2439594A1 Interleukin-8 homologous polypeptides and therapeutic uses thereof
09/12/2002CA2439531A1 A method of detecting nucleic acid molecules
09/12/2002CA2439504A1 Compositions and methods relating to osteoarthritis
09/12/2002CA2439402A1 Pcr method
09/12/2002CA2439312A1 Methods for global profiling gene regulatory element activity
09/12/2002CA2439205A1 Nuclear hormone receptor ligand binding domain
09/12/2002CA2439203A1 Nuclear hormone receptor ligand binding domain
09/12/2002CA2439200A1 Nuclear hormone receptor ligand binding domain
09/12/2002CA2439197A1 Nuclear hormone receptor ligand binding domain
09/12/2002CA2439196A1 Nuclear hormone receptor ligand binding domains
09/12/2002CA2439195A1 Nuclear hormone receptor ligand binding domain
09/12/2002CA2439192A1 Nuclear hormone receptor ligand binding domain
09/12/2002CA2439176A1 Assay for identifying inhibitors of the rna dependent rna polymerase (ns5b) of hcv
09/12/2002CA2438863A1 Polynucleotide encoding a novel human potassium channel beta-subunit, k+betam6, expressed highly in the small intestine
09/12/2002CA2438505A1 Altered peptide ligands
09/12/2002CA2432280A1 Novel glutamate receptor modulatory proteins and nucleic acid molecules and uses therefor
09/12/2002CA2431500A1 Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses
09/12/2002CA2428798A1 Fen-1 endonucleases from archaeoglobus veneficus
09/11/2002EP1239288A1 Identification of nucleotides, amino acids, or carbohydrates by mass spectrometry